By Tom Banse
NW News Network
An Australian company is eying property next to the soon-to-close coal power plant in Centralia, Washington, to build a big
HANGZHOU, China and SHAOXING, China, June 13, 2022 /PRNewswire/ Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), today announces the expansion of management team with appointment of Mr. John P. Gargiulo, former North America President and CEO of Daiichi Sankyo, as Chief Business Officer. Mr. John P. Gargiulo will lead Ascletis' corporate business development and alliance management in this new role and report to Dr. Jinzi J. Wu, PhD, Founder, Chairman and CEO of Ascletis. Mr. John P. Gargiulo has over 30 years of successful experience in marketing strategies, business integration and commercial operations in global pharma/biotech industry. He has held various senior positionswithincreasing responsibility for 18 years at Daiichi Sankyo, where he made a transformative contribution in driving Daiichi Sankyo's U.S. business from the very beginning to an established pharma when he served as North America President and CEO of Daiichi Sankyo. "John is a veteran in our i
/PRNewswire/ Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), today announces the expansion of management team with appointment of Mr. John P. Gargiulo,.
Ascletis Announces Appointment of Mr. John P. Gargiulo, Former North America President and CEO of Daiichi Sankyo, as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace